Michael Neely
Consultant

Xeris Pharmaceuticals

Is this your profile?

About

Michael Neely retired in 2015 after a 42-year career in the pharmaceutical industry. He currently serves in a consulting role for business development at Xeris Pharmaceuticals. His experience spans multiple disciplines, including pharmaceutical manufacturing, research and development, business development and marketing.

Contributions

ENABLING A NEW PARADIGM FOR PEPTIDE DRUG DEVELOPMENT

Michael Neely reviews peptide formulations and introduces Xeris's XeriSol™ technology and its potential paradigm-changing capabilities.

More contributions

A VIEW ON THE USE OF APROTIC SOLVENTS IN PARENTERAL DRUG FORMULATIONS

Michael Neely presents a review and discussion of the status of aprotic solvents as a solubilising vehicle for parenteral drug formulations in the context of the industry’s increasing interest in biologic drugs.

Top